oxybutynin has been researched along with Bladder Pain Syndrome in 7 studies
oxybutynin: RN given refers to parent cpd
oxybutynin : A racemate comprising equimolar amounts of (R)-oxybutynin and esoxybutynin. An antispasmodic used for the treatment of overactive bladder.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Intravesical instillation of TRG-100 was found to be safe and efficient in reducing pain and irritative bladder symptoms in our study population." | 5.91 | Open Label, Pilot Evaluation of the Safety and Efficacy of Intravesical Sustained Release System of Lidocaine and Oxybutynin (TRG-100) for Patients With Interstitial Cystitis/Bladder Pain Syndrome, Overactive Bladder and Patients With Retained Ureteral St ( Ala-Adin, N; Chertin, B; Dothan, D; Gordon, A; Hatumi, S; Kafka, I; Malchi, N; Moldwin, R; Nassar, T; Perez, D; Raisin, G; Shenfeld, O; Touitou, D, 2023) |
| "Interstitial cystitis is a condition with a poorly understood etiology and, consequently, various treatment options have been described in the literature, with a less than optimal outcome." | 2.73 | A rational combination of intravesical and systemic agents for the treatment of interstitial cystitis. ( Jawade, KK; Taneja, R, 2007) |
| "Intravesical instillation of TRG-100 was found to be safe and efficient in reducing pain and irritative bladder symptoms in our study population." | 1.91 | Open Label, Pilot Evaluation of the Safety and Efficacy of Intravesical Sustained Release System of Lidocaine and Oxybutynin (TRG-100) for Patients With Interstitial Cystitis/Bladder Pain Syndrome, Overactive Bladder and Patients With Retained Ureteral St ( Ala-Adin, N; Chertin, B; Dothan, D; Gordon, A; Hatumi, S; Kafka, I; Malchi, N; Moldwin, R; Nassar, T; Perez, D; Raisin, G; Shenfeld, O; Touitou, D, 2023) |
| "Interstitial cystitis/bladder pain syndrome (IC/BPS) is a chronic debilitating condition of unknown etiology." | 1.72 | Intravesical sustained release system of lidocaine and oxybutynin results from in vitro and animal study. ( Chertin, B; Dothan, D; Gordon, A; Malchi, N; Raisin, G; Touitou, D, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 2 (28.57) | 2.80 |
| Authors | Studies |
|---|---|
| Dothan, D | 2 |
| Raisin, G | 2 |
| Malchi, N | 2 |
| Gordon, A | 2 |
| Touitou, D | 2 |
| Chertin, B | 2 |
| Perez, D | 1 |
| Ala-Adin, N | 1 |
| Kafka, I | 1 |
| Shenfeld, O | 1 |
| Hatumi, S | 1 |
| Moldwin, R | 1 |
| Nassar, T | 1 |
| Matsuoka, PK | 1 |
| Haddad, JM | 1 |
| Pacetta, AM | 1 |
| Baracat, EC | 1 |
| Osman, NI | 1 |
| Chapple, CR | 1 |
| Taneja, R | 1 |
| Jawade, KK | 1 |
| Barbalias, GA | 1 |
| Liatsikos, EN | 1 |
| Athanasopoulos, A | 1 |
| Nikiforidis, G | 1 |
| Cannon, TW | 1 |
| Chancellor, MB | 1 |
2 reviews available for oxybutynin and Bladder Pain Syndrome
| Article | Year |
|---|---|
Intravesical treatment of painful bladder syndrome: a systematic review and meta-analysis.
Topics: Adjuvants, Immunologic; Administration, Intravesical; Anesthetics, Local; BCG Vaccine; Cystitis, Int | 2012 |
Pharmacotherapy of the overactive bladder and advances in drug delivery.
Topics: Administration, Intravesical; Antidepressive Agents, Tricyclic; Benzhydryl Compounds; Botulinum Toxi | 2002 |
2 trials available for oxybutynin and Bladder Pain Syndrome
| Article | Year |
|---|---|
A rational combination of intravesical and systemic agents for the treatment of interstitial cystitis.
Topics: Administration, Intravesical; Administration, Oral; Adult; Aged; Anti-Inflammatory Agents; Anticoagu | 2007 |
Interstitial cystitis: bladder training with intravesical oxybutynin.
Topics: Administration, Intravesical; Adult; Aged; Cystitis, Interstitial; Female; Humans; Mandelic Acids; M | 2000 |
3 other studies available for oxybutynin and Bladder Pain Syndrome
| Article | Year |
|---|---|
Intravesical sustained release system of lidocaine and oxybutynin results from in vitro and animal study.
Topics: Administration, Intravesical; Animals; Cystitis, Interstitial; Delayed-Action Preparations; Lidocain | 2022 |
Open Label, Pilot Evaluation of the Safety and Efficacy of Intravesical Sustained Release System of Lidocaine and Oxybutynin (TRG-100) for Patients With Interstitial Cystitis/Bladder Pain Syndrome, Overactive Bladder and Patients With Retained Ureteral St
Topics: Administration, Intravesical; Cystitis, Interstitial; Delayed-Action Preparations; Humans; Lidocaine | 2023 |
Lower urinary tract symptoms revisited.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adult; Aged; Benzhydryl Compounds; Cresols; Cystitis, Inter | 2012 |